Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels

Brain

Volumn 119, Issue 6, 1996, Pages 2121-2132

  Kulisevsky, Jaime ^a,c   Avila, Asuncion ^a   Barbanoj, Manel ^a   Antonijoan, Rosa ^a   Berthier, Marcelo L ^b   Gironell, Alexandre ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Cognition; Executive functions; Levodopa; Motor fluctuations; Parkinson's disease

Indexed keywords

LEVODOPA;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; DOPAMINERGIC SYSTEM; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; RESPONSE TIME; TASK PERFORMANCE; TIME; VERBAL MEMORY;

EID: 0030453470     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.6.2121     Document Type: Article

References (69)

1. Abercrombie ED, Bonatz AE, Zigmond MJ. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydoparaine-treated rats. Brain Res 1990; 525: 36-44.
2. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. [Review]. Annu Rev Neurosci 1986; 9: 357-81.
3. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. [Review]. Prog Brain Res 1990; 85: 119-46.
4. Arbit J, Boshes B, Blonsky R. Behavior and mentation changes during therapy. In: Barbeau A, McDowell FH, editors. L-Dopa and parkinsonism. Philadelphia: F.A. Davis, 1970: 329-36.
5. Baddeley A, Wilson B. Frontal amnesia and the dysexecutive syndrome. Brain Cogn 1988; 7: 212-30.
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
7. Bloxham CA, Dick DJ, Moore M. Reaction times and attention in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987; 50: 1178-83.
8. Boller F, Passafiume D, Keefe NC, Rogers K, Morrow L, Kim Y. Visuospatial impairment in Parkinson's disease: role of perceptual and motor factors. Arch Neurol 1984; 41: 485-90.
9. Brown RG, Marsden CD. Cognitive function in Parkinson's disease: from description to theory. [Review]. Trends Neurosci 1990; 13: 21-9.
10. Brown RG, Marsden CD. Dual task performance and processing resources in normal subjects and patients with Parkinson's disease. Brain 1991; 114: 215-31.
11. Brown RG, Marsden CD, Quinn N, Wyke MA. Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984; 47: 454-65.
12. Bowen FP, Kamienny RS, Burns MM, Yahr M. Parkinsonism: effects of levodopa treatment on concept formation. Neurology 1975; 25: 701-4.
13. Chase TN, Mouradian MM, Engber TM. Motor response complications and the function of striatal efferent systems. [Review]. Neurology 1993; 43 (12 Suppl 6): S23-7.
14. Cools AR, van den Bercken JHL, Horstink MWI, van Spaendonck KPM, Berger HJC. Cognitive and motor shifting aptitude disorder in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984; 47: 443-53.
15. Cooper JA, Sagar HJ. Incidental and intentional recall in Parkinson's disease: an account based on diminished attentional resources. J Clin Exp Neuropsychol 1993; 15: 713-31.
16. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991; 114: 2095-122.
17. Cooper JA, Sagar HJ, Doherty SM, Jordan N, Tidswell P, Sullivan EV. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. Brain 1992; 115: 1701-25.
18. Cummings JL. Frontal-subcortical circuits and human behavior. [Review]. Arch Neurol 1993; 50: 873-80.
19. Dalrymple-Alford JC, Kalders AS, Jones RD, Watson RW. A central executive deficit in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1994; 57: 360-7.
20. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 1989; 27: 1329-43.
21. Dubois B, Pillon B, Legault F, Agid Y, Lhermitte F. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. Arch Neurol 1988; 45: 1194-9.
22. Evarts EV, Teräväinen H, Calne DB. Reaction time in Parkinson's disease. Brain 1981; 104: 167-86.
23. Fabbrini G, Juncos J, Mouradian MM, Serrati C, Chase TN. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease. Ann Neurol 1987; 21: 370-6.
24. Fahn S, Elston RL and members of the UPDRS development committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson's disease, Vol. 2. New York: MacMillan, 1987: 153-63.
25. Flowers KA, Robertson C. The effect of Parkinson's disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatry 1985; 48: 517-29.
26. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
27. Girotti F, Carella F, Grassi MP, Soliveri P, Marano R, Caraceni T. Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease. J Neurol Neurosurg Psychiatry 1986; 49: 657-60.
28. Gotham AM, Brown RG, Marsden CD. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 1988; 111: 299-321.
29. Halgin R, Riklan M, Misiak H. Levodopa, parkinsonism, and recent memory. J Nerv Ment Dis 1977; 164: 268-72.
30. Heaton RK. Wisconsin Card Sorting Test. Manual. Odessa (FL): Psychological Assessment Resources, 1981.
31. Hietanen M, Teräväinen H. Cognitive performance in early Parkinson's disease. Acta Neurol Scand 1986; 73: 151-9.
32. Huber SJ, Shulman HG, Paulson GW, Shuttleworth EC. Fluctuations in plasma dopamine level impair memory in Parkinson's disease. Neurology 1987; 37: 1371-5.
33. Huber SJ, Shulman HG, Paulson GW, Shuttleworth EC. Dose-dependent memory impairment in Parkinson's disease. Neurology 1989; 39: 438-40.
34. Javoy-Agid F, Agid Y. Is the mesocortical dopaminergic system involved in Parkinson's disease? Neurology 1980; 30: 1326-30.
35. Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl) 1992; 107: 394-404.
36. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106: 257-70.
37. Lezak MD. Neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1983.
38. Malapani C, Pillon B, Dubois B, Agid Y. Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction. Neurology 1994; 44: 319-26.
39. Mayeux R, Stern Y, Sano M, Cote L, Williams JEW. Clinical and biochemical correlates of bradyphrenia in Parkinson's disease [published erratum appears in Neurology 1987; 37: 1693]. Neurology 1987; 37: 1130-4.
40. Meier MJ, Martin WE. Intellectual changes associated with levodopa therapy. JAMA 1970; 213: 465-6.
41. Melamed E, Hefti F, Pettibone DJ, Liebman J, Wurtman RJ. Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism. Neurology 1981; 31: 651-5.
42. Milner B. Effects of different brain lesions on card sorting. Arch Neurol 1963; 9: 90-100.
43. Mohr E, Fabbrini G, Ruggieri S, Fedio P, Chase TN. Cognitive concomitants of dopamine system stimulation in parkinsonian patients. J Neurol Neurosurg Psychiatry 1987; 50: 1192-6.
44. Nutt JG. On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics. [Review]. Ann Neurol 1987; 22: 535-40.
45. Owen AM, Beksinska M, James M, Lange KW, Summers BA, Leigh PN et al. Dopamine dependent spatial working memory deficits in Parkinson's disease [abstract]. Soc Neurosci Abstr 1991; 17: 1261.
46. Pillon B, Dubois B, Bonnet A-M, Esteguy M, Guimaraes J, Vigouret JM, et al. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology 1989; 39: 762-8.
47. Poewe W, Berger W, Benke Th, Schelosky L. High-speed memory scanning in Parkinson's disease: adverse effects of levodopa. Ann Neurol 1991; 29: 670-3.
48. Portin R, Rinne UK. Neuropsychological responses of parkinsonian patients to long-term levodopa treatment. In: Rinne UK, Klinger M, Stamm G, editors. Parkinson's disease: current progress, problems and management. Amsterdam: Elsevier North-Holland, 1980: 271-304.
49. Portin R, Rinne UK. Predictive factors for cognitive deterioration and dementia in Parkinson's disease. Adv Neurol 1987; 45: 413-6.
50. Pullman SL, Watts RL, Juncos JL, Chase TN, Sanes JN. Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease. Neurology 1988; 38: 249-54.
51. Rafal RD, Posner MI, Walker JA, Friedrich FJ. Cognition and the basal ganglia. Brain 1984; 107: 1083-94.
52. Richards M, Cote LJ, Stern Y. Executive function in Parkinson's disease: set-shifting or set-maintenance? J Clin Exp Neuropsychol 1993; 15: 266-79.
53. Riklan M, Whelihan W, Cullinan T. Levodopa and psychometric test performance in parkinsonism: 5 years later. Neurology 1976; 26: 173-9.
54. Rogers D, Lees AJ, Smith E, Trimble M, Stern GM. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness: an experimental study. Brain 1987; 110: 761-76.
55. Saint-Cyr JA, Taylor AE, Lang AE. Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease. [Review]. Neurology 1993; 43 (12 Suppl 6): S47-52.
56. Scatton B, Rouquier L, Javoy-Agid F, Agid Y. Dopamine deficiency in the cerebral cortex in Parkinson's disease. Neurology 1982; 32: 1039-40.
57. Shoulson I, Glaubiger GA, Chase TN. On-off response: clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology 1975; 25: 1144-8.
58. Spielberg CD, Gorsuch RL, Lushene RE. STAI Manual for the State-Trait Anxiety Inventory. Palo Alto (CA): Consulting Psychologists Press, 1970.
59. Starkstein SE, Esteguy M, Berthier ML, García H, Leiguarda L. Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson's disease. J Neurol Neurosurg Psychiatry 1989; 52: 338-40.
60. Sternberg S. High-speed scanning in human memory. Science 1966; 153: 652-4.
61. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643-62.
62. Stuss DT, Eskes GA, Foster JK. Experimental neuropsychological studies of frontal lobe functions. In: Boiler F, Grafman J, editors. Handbook of neuropsychology, Vol.9. Amsterdam: Elsevier, 1994: 149-85.
63. Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson's disease. Brain 1986; 109: 845-83.
64. van Horne C, Hoffer BJ, Strömberg I, Gerhardt GA. Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum J Pharmacol Exp Ther 1992; 263: 1285-92.
65. Wagner J, Vitali P, Palfreyman MG, Zraika M, Huot S. Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, doparaine, 4-hydroxy-3-methoxyphenylalanine, norepinephrine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonine, and 5-hydroxyindoleacetic acid in rat cerebrospinal fluid and brain by high-performance liquid chromatography with electrochemical detection. J Neurochem 1982; 38: 1241-54.
66. Warburton JW. Memory disturbance and the Parkinson syndrome. Br J Med Psychol 1967; 40: 169-71.
67. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945; 19: 87-95.
68. Wilson RS, Kaszniak AW, Klawans HL, Garron DC. High speed memory scanning in parkinsonism. Cortex 1980; 16: 67-72.
69. Zhang WQ, Tilson HA, Nanry KP, Hudson PM, Hong JS, Stachowiak MK. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Brain Res 1988; 461: 335-42.